Loading clinical trials...
Loading clinical trials...
The objective of this study is to evaluate mycobacteriophage therapy using in-vitro validated mycobacteriophage DP-QB-MYA-002 in combination with conventional antimycobacterial agents for the treatmen...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Alberta Health services
NCT07192705 · Non-Tuberculous Mycobacteria Pulmonary Disease, Bronchiectasis
NCT07579052 · Chronic Obstructive Pulmonary Disease
NCT06847061 · Chronic Obstructive Pulmonary Disease (COPD
NCT05061368 · Chronic Obstructive Pulmonary Disease
NCT05746039 · Obesity, Interstitial Lung Disease, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions